GTR 107501203
Tenders Are Invited For Faricimab (Genetical Recombination) 28.8Mg 180 Vials,Satralizumab(Genetical Recombination) 120Mg 54 Vials,Ravulizumab(Genetical Recombination) 300Mg 314 Vials,Epcoritamab(Genetical Recombination) 48Mg 21 Vials,Axicabtagene Ciloleucel 8 Set ,Idecabtagene Vicleucel 3 Set ,Lisocabtagene Mar...
ICB — International Competitive Bid
Closed
Asia
Tender Information
GTR Reference
107501203
Tendering Authority
Subscribe to view
Tender No
378980
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Faricimab (Genetical Recombination) 28.8Mg 180 Vials,Satralizumab(Genetical Recombination) 120Mg 54 Vials,Ravulizumab(Genetical Recombination) 300Mg 314 Vials,Epcoritamab(Genetical Recombination) 48Mg 21 Vials,Axicabtagene Ciloleucel 8 Set ,Idecabtagene Vicleucel 3 Set ,Lisocabtagene Mar...
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Asia
Political Region
Asia-Pacific Economic Cooperation, APEC,G20,APAC (Asia Pacific)
Last Date of Bid Submission
09-03-2026
Closed
Work Detail
Faricimab (Genetical Recombination) 28.8Mg 180 Vials,Satralizumab(Genetical Recombination) 120Mg 54 Vials,Ravulizumab(Genetical Recombination) 300Mg 314 Vials,Epcoritamab(Genetical Recombination) 48Mg 21 Vials,Axicabtagene Ciloleucel 8 Set ,Idecabtagene Vicleucel 3 Set ,Lisocabtagene Mar...
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
b2140f04-160e-4ecf-a031-124c17517342.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.